Hankang Capital
Overview
Hankang Capital, established in 2010, is a corporate venture capital firm of Zhongjianxin Group headquartered in Shanghai, China . The firm focuses on investments in sectors like biomedicine, medical equipment, diagnostic reagents, medical services, and other major health fields .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Sirius Therapeutics, Inc. | May 2025 | Series B Extension | Co-investor |
| HanBio Therapeutics | Jan 2022 | Series A | Lead |
| VelaVigo | Jul 2025 | VC Round | Co-investor |
| BriSTAR Immunotech | Jan 2020 | Series A Extension | Lead |
| Shanghai Angsheng Biomedical Technology Co., Ltd. | May 2025 | Series A | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Hankang Capital based?
Hankang Capital is headquartered in Shanghai, Shanghai, China.
When was Hankang Capital founded?
Hankang Capital was founded in 2010.
How many portfolio companies does Hankang Capital have?
Hankang Capital has 16 portfolio companies in Caplight's dataset.
What are some companies in Hankang Capital's portfolio?
Portfolio companies visible on Caplight include Sirius Therapeutics, Inc., HanBio Therapeutics, VelaVigo, BriSTAR Immunotech, Shanghai Angsheng Biomedical Technology Co., Ltd..
What was Hankang Capital's most recent investment shown here?
Hankang Capital's most recent investment in this portfolio sample was in VelaVigo in 2025.
What sectors does Hankang Capital focus on?
Hankang Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, AI, Data & Cloud Infrastructure.
What company stages does Hankang Capital focus on?
Hankang Capital typically invests at the Mid stage.
What is Hankang Capital's AUM?
Hankang Capital's assets under management are estimated between $500.0M and $1.0B.